feed info
6 articles from EurekAlert
All-female scientific coalition calls for marine protected area for Antarctica Peninsula
- EurekAlert
- 20/10/18 06:00
Species on the Antarctic Peninsula are threatened by climate change and human activities including commercial fishing, tourism, and research infrastructure. A coalition of over 280 female scientists are pushing for a Marine Protected Area ahead of a meeting of governments to decide this on October 19. These women are part of an initiative to raise the profile of women in STEMM for better global...
Big babies could be at higher risk of common heart rhythm disorder in adulthood
- EurekAlert
- 20/10/18 06:00
Elevated birth weight is linked with developing atrial fibrillation later in life, according to research presented at the 31st Great Wall International Congress of Cardiology (GW-ICC).
IVF success rates higher at clinics that provide more outcomes data
- EurekAlert
- 20/10/18 06:00
Success rates for in vitro fertilization are higher at clinics that voluntarily share more information than required by government regulators, according to new research by faculty at the University of Colorado School of Medicine. In a review of data reported between 2014 and 2017, CU researchers found that clinics that reported more data than required by the Centers for Disease Control and...
Losing flight had huge benefits for ants, finds new study
- EurekAlert
- 20/10/18 06:00
Researchers have taken detailed scans of worker ants to examine the hypothesis that the loss of flight is directly connected to the evolution of strength.
Mystery over decline in sea turtle sightings
- EurekAlert
- 20/10/18 06:00
The number of sea turtles spotted along the coasts of the UK and Ireland has declined in recent years, researchers say.
Oncotarget: Th1 cytokines potentiate apoptosis of breast cancer cells and suppress tumor growth
- EurekAlert
- 20/10/18 06:00
Volume 11, Issue 30 of Oncotarget reported that previously, the authors showed that anti-estrogen drugs combined with a dendritic cell-based anti-HER-2 vaccine known to induce strong Th1-polarized immunity dramatically improved clinical response rates in patients with HER-2pos/ERpos early breast cancer.